Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144781
Status:
COMPLETED
Last Update Posted:
2015-04-03
First Post:
2005-09-02
Brief Title:
A Dose-optimization Study of Aldurazyme Laronidase in Patients With Mucopolysaccharidosis I MPS I Disease
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mucopolysaccharidosis I |
| Hurlers Syndrome |
| Hurler-Scheie Syndrome |
| Scheie Syndrome |
Keywords: